Sun Pharma eyes full acquisition of Israeli firm via reverse triangular merger

Sun Pharma eyes full acquisition of Israeli firm via reverse triangular merger

The Mumbai-based drug major said it has issued a letter to the Taro board with a proposal containing a non-binding indication of interest.

PTIUpdated: Saturday, May 27, 2023, 09:12 PM IST
article-image
Image: Sun Pharma (Representative)

Sun Pharmaceutical Industries on Saturday said it has proposed to fully acquire Israel-based Taro Pharmaceutical Industries through a reverse triangular merger.

The Mumbai-based drug major said it has issued a letter to the Taro board with a proposal containing a non-binding indication of interest to acquire all of the outstanding ordinary shares for a purchase price of USD 38 per ordinary share in cash.

Sun Pharma currently owns a 78.48 per cent stake in Taro. "We envisage the proposed transaction to be consummated in the form of a reverse triangular merger under the Israeli Companies Law, 1999 and practice," Sun Pharma said in a regulatory filing.

The purchase price represents a premium of 31.2 per cent over Taro's closing price on May 25, 2023, a 41.5 per cent premium over Taro's average closing price in the last 60 days and a compelling liquidity opportunity for Taro's shareholders, it added.

Under the indicative proposal, post the acquisition, Taro will become a wholly-owned subsidiary of Sun Pharma and will be delisted from NYSE.

RECENT STORIES

Banks To Stay Open On Sunday: Upon Government Request, RBI Asks Lenders To Function On March 31

Banks To Stay Open On Sunday: Upon Government Request, RBI Asks Lenders  To Function On March 31

Stock Market News: Indian Indices To Remain Shut Today On Account Of Good Friday

Stock Market News: Indian Indices To Remain Shut Today On Account Of Good Friday

How Does SIP Help You Create Wealth in the Long Term?

How Does SIP Help You Create Wealth in the Long Term?

The Disruptive Potential of AI in Stock Market Trading: Rohan Menon's Perspective

The Disruptive Potential of AI in Stock Market Trading: Rohan Menon's Perspective

Analysis: Anonymous Electoral Bonds Reined In — But What About Anonymous Cash Donations?

Analysis: Anonymous Electoral Bonds Reined In — But What About Anonymous Cash Donations?